Sign Up to like & get
recommendations!
1
Published in 2022 at "Drug Development and Industrial Pharmacy"
DOI: 10.1080/03639045.2022.2048665
Abstract: Abstract Objective To investigate the inhibitory nature of hydroxychavicol against the COVID-19 associated mycotic infections, the present in silico study was performed in hydroxychavicol with the target Lanosterol 14 alpha demethylase and its competency was…
read more here.
Keywords:
mycotic infections;
covid associated;
anti fungal;
hydroxychavicol ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Oral Microbiology"
DOI: 10.1080/20002297.2021.1967699
Abstract: ABSTRACT Introduction Bacterial and fungal secondary infections following COVID-19 disease are widely being reported and are an area that should receive careful attention. Mucormycosis is a fatal fungal condition affecting immunocompromised patients caused by a…
read more here.
Keywords:
candidiasis;
covid patients;
oral candidiasis;
mycotic infections ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.13782
Abstract: To determine the risk of mycotic infections associated with the use of sodium–glucose co‐transporter 2 inhibitors (SGLT2i) in a real‐world setting.
read more here.
Keywords:
sodium glucose;
glucose transporter;
risk mycotic;
mycotic infections ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Diabetes"
DOI: 10.2337/db19-1224-p
Abstract: Background: Sodium-glucose co-transporter-2 (SGLT2) inhibitors have now become established as important second line agents for the management of type 2 diabetes, and are known to have clinical glycaemic, renal and cardiovascular benefits. The development of…
read more here.
Keywords:
hygiene advice;
mycotic infections;
genital mycotic;
sglt2 inhibitors ... See more keywords